Comparison of three questionnaire forms used in the diagnosis of lower urinary tract symptoms: A prospective study.
Education
Lower urinary tract symptoms
Patient health questionnaire
Prostate
Prostatic hyperplasia
Journal
Prostate international
ISSN: 2287-8882
Titre abrégé: Prostate Int
Pays: Korea (South)
ID NLM: 101605566
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
01
04
2022
revised:
16
05
2022
accepted:
01
06
2022
entrez:
26
12
2022
pubmed:
27
12
2022
medline:
27
12
2022
Statut:
ppublish
Résumé
Questionnaire forms (QFs) are used in the evaluation of all patients presenting with lower urinary tract symptoms (LUTSs). Our study aims to investigate the compatibility of the three QFs with each other and to investigate the relationship between education level and complete completion of these forms. A total of 224 patients between February 2018 and February 2019 were included. The patients were divided into 3 groups as primary, intermediate, and advanced according to their education level and the patients who gave incomplete answers to the questions were determined. The mean age of the patients was 61.0 ± 7.57(45-85), International Prostate Symptom Score (IPSS) value was 16.2 ± 8.3(1-35), the international incontinence form-male lower urinary tract symptoms (ICIQ-MLUTS) value was 16.5 ± 7.9(0-38), the visual prostate symptom score (VPSS) value was 9.9 ± 3.0(3-16). There was a significant correlation between the three QFs ( Each QF has its advantages and disadvantages. The strong correlation between IPSS and ICIQ-MLUTS found in our study indicates that these tools can be used interchangeably in daily clinical practice. ICIQ-MLUTS can evaluate symptoms that are not present in other QFs. In the evaluation of illiterate patients, VPSS should be used without any alternative.
Identifiants
pubmed: 36570650
doi: 10.1016/j.prnil.2022.06.001
pii: S2287-8882(22)00035-6
pmc: PMC9747591
doi:
Types de publication
Journal Article
Langues
eng
Pagination
218-223Informations de copyright
© 2022 Asian Pacific Prostate Society. Publishing services by Elsevier B.V.
Déclaration de conflit d'intérêts
All authors have no conflict of interest to declare.
Références
Prostate Int. 2021 Dec;9(4):215-220
pubmed: 35059360
Aging Male. 2018 Sep;21(3):193-199
pubmed: 29228847
Int J Clin Pract. 2015 Mar;69(3):358-65
pubmed: 25648652
J Urol. 2013 Jan;189(1 Suppl):S93-S101
pubmed: 23234640
Prostate Int. 2014 Dec;2(4):176-81
pubmed: 25599073
J Urol. 1997 Apr;157(4):1295-300
pubmed: 9120925
Int Neurourol J. 2016 Jun;20(2):159-63
pubmed: 27377949
Neurourol Urodyn. 2019 Feb;38(2):433-477
pubmed: 30681183
Prostate Int. 2018 Sep;6(3):115-118
pubmed: 30140662
Prostate Int. 2022 Sep;10(3):162-168
pubmed: 36225281
Urology. 2015 Mar;85(3):653-7
pubmed: 25733282
Eur Urol. 2007 Sep;52(3):811-8
pubmed: 17276583
J Urol. 1998 Jan;159(1):191-4
pubmed: 9400470
Health Technol Assess. 2020 Sep;24(42):1-122
pubmed: 32902375
J Urol. 2020 Nov;204(5):1003-1011
pubmed: 32469267
J Urol. 2000 Dec;164(6):1948-55
pubmed: 11061889
J Urol. 1998 Mar;159(3):873-4
pubmed: 9474172
J Urol. 1995 Jul;154(1):97-9
pubmed: 7539870
Iran J Nurs Midwifery Res. 2018 Nov-Dec;23(6):421-425
pubmed: 30386390
J Urol. 1992 Nov;148(5):1549-57; discussion 1564
pubmed: 1279218
Indian J Urol. 2020 Apr-Jun;36(2):123-129
pubmed: 32549664
Urology. 2011 Jul;78(1):17-20
pubmed: 21550646